Public signalCompany raiseAuto-indexed · Unverified

IN8BIO, INC. raised $20.1M

IN8BIO, INC.· NEW YORK, US· Biotechnology· Filed Dec 30, 2025

IN8BIO, INC. reported raising capital. Based in NEW YORK, NEW YORK, US. First sale reported 2025-12-22. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.

Raised
$20.1M
Confidence90%

On the record

Location
NEW YORK, US
Sector
Biotechnology
Record type
Company raise
Stage
Reported raised
Amount raised
$20.1M
Target amount
$40.2M
Filing date
Dec 30, 2025
Issuer type
operating company

Gaps in the record

  • Valuation and deal terms are not on the public record
  • No company website on record
  • Investors are not disclosed
  • Not yet claimed or verified by the company

Sources & provenance

Operating company sold 20,119,049 USD under Reg D.

View original filing (SEC EDGAR Form D)

Automatically indexed from SEC EDGAR Form D · filing dated Dec 30, 2025. Details beyond the filing have not been verified.

Tags

USCompanyBiotechnology$10M – $100MCompany Raise

Are you associated with IN8BIO, INC.?

This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.

Claim this record